• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫梯度指标用于通过自动肿瘤-基质界面区检测评估抗肿瘤反应。

Immunogradient Indicators for Antitumor Response Assessment by Automated Tumor-Stroma Interface Zone Detection.

机构信息

National Center of Pathology, Vilnius University Hospital Santaros Clinics, Vilnius, Lithuania; Department of Pathology, Forensic Medicine and Pharmacology, Institute of Biomedical Sciences, Vilnius University, Vilnius, Lithuania.

National Center of Pathology, Vilnius University Hospital Santaros Clinics, Vilnius, Lithuania; Department of Pathology, Forensic Medicine and Pharmacology, Institute of Biomedical Sciences, Vilnius University, Vilnius, Lithuania.

出版信息

Am J Pathol. 2020 Jun;190(6):1309-1322. doi: 10.1016/j.ajpath.2020.01.018. Epub 2020 Mar 17.

DOI:10.1016/j.ajpath.2020.01.018
PMID:32194048
Abstract

The distribution of tumor-infiltrating lymphocytes (TILs) within the tumor microenvironment provides strong prognostic value, which is increasingly important with the arrival of new immunotherapy modalities. Both visual and image analysis-based assays are developed to assess the immune contexture of the tumors. We propose an automated method based on grid subsampling of microscopy image analysis data to extract the tumor-stroma interface zone (IZ) of controlled width. The IZ is a ranking of tissue areas by their distance to the tumor edge, which is determined by a set of explicit rules. TIL density profiles across the IZ are used to compute a set of novel immunogradient indicators that reflect TIL gradient towards the tumor. We applied this method on CD8 immunohistochemistry images of surgically excised hormone receptor-positive breast and colorectal cancers to predict overall patient survival. In both cohorts, the immunogradient indicators enabled strong and independent prognostic stratification, outperforming clinical and pathologic variables. Patients with breast cancer with low immunogradient levels had a prominent decrease in survival probability 5 years after surgery. Our study provides proof of concept that data-driven, automated, operator-independent IZ sampling enables spatial immune response measurement in the tumor-host interaction frontline for prediction of disease outcomes.

摘要

肿瘤浸润淋巴细胞 (TILs) 在肿瘤微环境中的分布提供了强大的预后价值,随着新的免疫治疗模式的出现,这一点变得越来越重要。目前已经开发出基于视觉和图像分析的检测方法来评估肿瘤的免疫结构。我们提出了一种基于显微镜图像分析数据网格抽样的自动化方法,以提取具有可控宽度的肿瘤-基质界面区 (IZ)。IZ 是根据距离肿瘤边缘的组织区域的距离对组织区域进行排序的,这是通过一组明确的规则来确定的。在 IZ 上,TIL 密度分布用于计算一组新的免疫梯度指标,这些指标反映了 TIL 向肿瘤的梯度。我们将该方法应用于手术切除的激素受体阳性乳腺癌和结直肠癌的 CD8 免疫组化图像,以预测患者的总体生存情况。在两个队列中,免疫梯度指标均能够进行强有力的独立预后分层,优于临床和病理变量。手术后 5 年,乳腺癌患者的免疫梯度水平较低,其生存率显著下降。我们的研究提供了一个概念验证,即数据驱动、自动化、无需操作人员干预的 IZ 采样能够在肿瘤-宿主相互作用的前沿进行空间免疫反应测量,从而预测疾病结局。

相似文献

1
Immunogradient Indicators for Antitumor Response Assessment by Automated Tumor-Stroma Interface Zone Detection.免疫梯度指标用于通过自动肿瘤-基质界面区检测评估抗肿瘤反应。
Am J Pathol. 2020 Jun;190(6):1309-1322. doi: 10.1016/j.ajpath.2020.01.018. Epub 2020 Mar 17.
2
CD8+ T cell infiltration in breast and colon cancer: A histologic and statistical analysis.CD8+ T 细胞浸润在乳腺癌和结肠癌中的研究:组织学和统计学分析。
PLoS One. 2018 Jan 10;13(1):e0190158. doi: 10.1371/journal.pone.0190158. eCollection 2018.
3
Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer.结直肠癌肺转移灶中的肿瘤浸润淋巴细胞亚群和三级淋巴结构
Clin Exp Metastasis. 2016 Oct;33(7):727-39. doi: 10.1007/s10585-016-9813-y. Epub 2016 Jul 23.
4
Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study.肿瘤浸润淋巴细胞(TILs)的形态学评估以研究浸润性乳腺癌的免疫原性、揭示淋巴细胞网络并辅助复发预测:一项回顾性研究
Int J Mol Sci. 2017 Sep 8;18(9):1936. doi: 10.3390/ijms18091936.
5
Intratumoral Heterogeneity and Immune Response Indicators to Predict Overall Survival in a Retrospective Study of HER2-Borderline (IHC 2+) Breast Cancer Patients.一项关于HER2临界(免疫组化2+)乳腺癌患者的回顾性研究中,肿瘤内异质性和免疫反应指标对总生存期的预测作用
Front Oncol. 2021 Nov 11;11:774088. doi: 10.3389/fonc.2021.774088. eCollection 2021.
6
Prognostic Implications of Tumor-Infiltrating Lymphocytes in Association With Programmed Death Ligand 1 Expression in Early-Stage Breast Cancer.肿瘤浸润淋巴细胞与程序性死亡配体1表达在早期乳腺癌中的预后意义
Clin Breast Cancer. 2016 Feb;16(1):51-8. doi: 10.1016/j.clbc.2015.07.006. Epub 2015 Aug 6.
7
Baseline Peripheral Blood Leukocytosis Is Negatively Correlated With T-Cell Infiltration Predicting Worse Outcome in Colorectal Cancers.基线外周血白细胞增多与 T 细胞浸润呈负相关,提示结直肠癌预后不良。
Front Immunol. 2018 Oct 12;9:2354. doi: 10.3389/fimmu.2018.02354. eCollection 2018.
8
Intratumoral infiltrating lymphocytes correlate with improved survival in colorectal cancer patients: Independent of oncogenetic features.肿瘤内浸润淋巴细胞与结直肠癌患者的生存改善相关:与肿瘤遗传特征无关。
J Cell Physiol. 2019 Apr;234(4):4768-4777. doi: 10.1002/jcp.27273. Epub 2018 Oct 28.
9
Immune infiltrates in the breast cancer microenvironment: detection, characterization and clinical implication.乳腺癌微环境中的免疫浸润:检测、特征及临床意义
Breast Cancer. 2017 Jan;24(1):3-15. doi: 10.1007/s12282-016-0698-z. Epub 2016 May 2.
10
A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: a retrospective study.结直肠癌原发灶与转移灶局部免疫状态的比较:一项回顾性研究。
BMC Cancer. 2018 Apr 3;18(1):371. doi: 10.1186/s12885-018-4276-y.

引用本文的文献

1
The Immune Environment in Colorectal Adenoma: A Systematic Review.结直肠腺瘤中的免疫环境:一项系统综述
Biomedicines. 2025 Mar 12;13(3):699. doi: 10.3390/biomedicines13030699.
2
Interaction of human gut microbiota and local immune system in progression of colorectal adenoma (MIMICA-1): a protocol for a prospective, observational cohort study.结直肠腺瘤进展过程中人类肠道微生物群与局部免疫系统的相互作用(MIMICA-1):一项前瞻性观察队列研究方案
Front Oncol. 2025 Jan 6;14:1495635. doi: 10.3389/fonc.2024.1495635. eCollection 2024.
3
Spatial distributions of CD8 and Ki67 cells in the tumor microenvironment independently predict breast cancer-specific survival in patients with ER+HER2- and triple-negative breast carcinoma.
肿瘤微环境中 CD8 和 Ki67 细胞的空间分布独立预测 ER+/HER2- 和三阴性乳腺癌患者的乳腺癌特异性生存。
PLoS One. 2024 Nov 22;19(11):e0314364. doi: 10.1371/journal.pone.0314364. eCollection 2024.
4
Automated scoring methods for quantitative interpretation of Tumour infiltrating lymphocytes (TILs) in breast cancer: a systematic review.用于乳腺癌肿瘤浸润淋巴细胞(TILs)定量解读的自动化评分方法:系统综述。
BMC Cancer. 2024 Sep 30;24(1):1202. doi: 10.1186/s12885-024-12962-8.
5
Low CD8+ Density Variation and R1 Surgical Margin as Independent Predictors of Early Post-Resection Recurrence in HCC Patients Meeting Milan Criteria.低 CD8+ 密度变化和 R1 手术切缘是符合米兰标准 HCC 患者术后早期复发的独立预测因素。
Curr Oncol. 2024 Sep 10;31(9):5344-5353. doi: 10.3390/curroncol31090394.
6
Improving HCC Prognostic Models after Liver Resection by AI-Extracted Tissue Fiber Framework Analytics.通过人工智能提取的组织纤维框架分析改进肝切除术后肝癌预后模型
Cancers (Basel). 2023 Dec 24;16(1):106. doi: 10.3390/cancers16010106.
7
Artificial Intelligence in Breast Cancer Diagnosis and Personalized Medicine.人工智能在乳腺癌诊断与个性化医疗中的应用
J Breast Cancer. 2023 Oct;26(5):405-435. doi: 10.4048/jbc.2023.26.e45.
8
Deep learning model improves tumor-infiltrating lymphocyte evaluation and therapeutic response prediction in breast cancer.深度学习模型改善乳腺癌中肿瘤浸润淋巴细胞评估及治疗反应预测
NPJ Breast Cancer. 2023 Aug 30;9(1):71. doi: 10.1038/s41523-023-00577-4.
9
Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.肿瘤免疫细胞浸润的空间分析:当前方法与未来方向:乳腺癌国际免疫肿瘤生物标志物工作组报告。
J Pathol. 2023 Aug;260(5):514-532. doi: 10.1002/path.6165. Epub 2023 Aug 23.
10
Multi-scale spatial modeling of immune cell distributions enables survival prediction in primary central nervous system lymphoma.免疫细胞分布的多尺度空间建模能够预测原发性中枢神经系统淋巴瘤的生存率。
iScience. 2023 Jul 10;26(8):107331. doi: 10.1016/j.isci.2023.107331. eCollection 2023 Aug 18.